These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

664 related items for PubMed ID: 28125452

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
    Hoang LN, McConechy MK, Köbel M, Han G, Rouzbahman M, Davidson B, Irving J, Ali RH, Leung S, McAlpine JN, Oliva E, Nucci MR, Soslow RA, Huntsman DG, Gilks CB, Lee CH.
    Am J Surg Pathol; 2013 Sep; 37(9):1421-32. PubMed ID: 24076778
    [Abstract] [Full Text] [Related]

  • 3. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
    Lim D, Murali R, Murray MP, Veras E, Park KJ, Soslow RA.
    Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.
    Mackenzie R, Talhouk A, Eshragh S, Lau S, Cheung D, Chow C, Le N, Cook LS, Wilkinson N, McDermott J, Singh N, Kommoss F, Pfisterer J, Huntsman DG, Köbel M, Kommoss S, Gilks CB, Anglesio MS.
    Am J Surg Pathol; 2015 Nov; 39(11):1548-57. PubMed ID: 26099008
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
    Ramalingam P.
    Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
    [Abstract] [Full Text] [Related]

  • 8. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A.
    Wu CH, Mao TL, Vang R, Ayhan A, Wang TL, Kurman RJ, Shih IeM.
    Int J Gynecol Pathol; 2012 Jul; 31(4):297-303. PubMed ID: 22653341
    [Abstract] [Full Text] [Related]

  • 9. Accurate Distinction of Ovarian Clear Cell From Endometrioid Carcinoma Requires Integration of Phenotype, Immunohistochemical Predictions, and Genotype: Implications for Lynch Syndrome Screening.
    Rodriguez M, Kang EY, Farrington K, Cook LS, Le ND, Karnezis AN, Lee CH, Nelson GS, Terzic T, Lee S, Köbel M.
    Am J Surg Pathol; 2021 Nov 01; 45(11):1452-1463. PubMed ID: 34534137
    [Abstract] [Full Text] [Related]

  • 10. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
    Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT.
    Am J Surg Pathol; 2016 Mar 01; 40(3):419-32. PubMed ID: 26551622
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
    Soslow RA, Wethington SL, Cesari M, Chiappetta D, Olvera N, Shia J, Levine DA.
    Am J Surg Pathol; 2012 Dec 01; 36(12):1771-81. PubMed ID: 23154767
    [Abstract] [Full Text] [Related]

  • 12. Comprehensive genomic profiling reveals ubiquitous KRAS mutations and frequent PIK3CA mutations in ovarian seromucinous borderline tumor.
    Wu RC, Chen SJ, Chen HC, Tan KT, Jung SM, Lin CY, Chao AS, Huang KG, Chou HH, Chang TC, Chao A, Lai CH.
    Mod Pathol; 2020 Dec 01; 33(12):2534-2543. PubMed ID: 32616873
    [Abstract] [Full Text] [Related]

  • 13. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I, D'Angelo E, Corominas M, Gonzalez A, Prat J.
    Hum Pathol; 2018 Jan 01; 71():65-73. PubMed ID: 29079180
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas.
    Ritterhouse LL, Nowak JA, Strickland KC, Garcia EP, Jia Y, Lindeman NI, Macconaill LE, Konstantinopoulos PA, Matulonis UA, Liu J, Berkowitz RS, Nucci MR, Crum CP, Sholl LM, Howitt BE.
    Mod Pathol; 2016 Aug 01; 29(8):893-903. PubMed ID: 27150160
    [Abstract] [Full Text] [Related]

  • 16. [Clinicopathologic study of seromucinous carcinoma of ovary].
    Tang SX, Sun YH, Xu Y, Zhou XR, Yang WT.
    Zhonghua Bing Li Xue Za Zhi; 2016 Nov 08; 45(11):774-779. PubMed ID: 27821232
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma.
    Kim WY, Shim SH, Jung HY, Dong M, Kim SN, Lee SJ.
    Hum Pathol; 2017 Jun 08; 64():98-105. PubMed ID: 28428108
    [Abstract] [Full Text] [Related]

  • 20. Mutation of NRAS is a rare genetic event in ovarian low-grade serous carcinoma.
    Xing D, Suryo Rahmanto Y, Zeppernick F, Hannibal CG, Kjaer SK, Vang R, Shih IM, Wang TL.
    Hum Pathol; 2017 Oct 08; 68():87-91. PubMed ID: 28873354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.